Valeo Financial Advisors, LLC - PHIO PHARMACEUTICALS CORP ownership

PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 19 filers reported holding PHIO PHARMACEUTICALS CORP in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Valeo Financial Advisors, LLC ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2021$11,000
+1000.0%
4,000
+1500.0%
0.00%
Q2 2020$1,0002500.00%
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
CVI Holdings, LLC 360,094$637,0002.24%
SABBY MANAGEMENT, LLC 255,194$452,0000.19%
EDMOND DE ROTHSCHILD HOLDING S.A. 12,500$22,0000.00%
UBS Group AG 563$1,0000.00%
BANK OF AMERICA CORP /DE/ 1$00.00%
WELLS FARGO & COMPANY/MN 18$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HSBC HOLDINGS PLC 12,375$22,0000.00%
MORGAN STANLEY 86$00.00%
BlackRock Inc. 19$00.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders